Abnova (Taiwan) Corporation

Equities

4133

TW0004133004

Biotechnology & Medical Research

End-of-day quote Taiwan S.E. Other stock markets 06:00:00 2024-05-02 pm EDT			5-day change	1st Jan Change
31.4 ^TWD	-0.63%		+0.80%	-10.54%

Feb. 29	Abnova Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Feb. 20	Abnova Corporation Approves Dividend Distribution for the Year 2023	CI

Abnova Corporation Elects Members of the Company's Remuneration Committee

May 15, 2023 at 04:37 am EDT

Abnova (Taiwan) Corporation elected members of the company's remuneration committee. Name of the previous position holder: Independent Director: Lin Jia Hsie; Independent Director: Ye Shao De; Independent Director: Su Jin Jun. Resume of the previous position holder: Lin Jia Hsie: Chairperson of Zero One Technology Co.

Ltd.; Ye Shao De: Chairperson of Cancer Center,Taipei Medical University Hospital; Su Jin Jun: Professor and Dean of School of International Business, TKK College, Xiamen University. .Name of the new position holder: Independent Director: Ye Shao De; Independent Director: Su Jin Jun; Independent Director: Cha Anna. Resume of the new position holder: Ye Shao De: Chairperson of Cancer Center,Taipei Medical University Hospital; Su Jin Jun: Professor and Dean of School of International Business, TKK College, Xiamen University; Cha Anna: Chairperson of Rouge Creative Marketing Co.

Effective date of the new member: May 15, 2023.

Latest news about Abnova (Taiwan) Corporation

Abnova Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29	CI
Abnova Corporation Approves Dividend Distribution for the Year 2023	Feb. 20	CI
Abnova Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09	CI
Abnova Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-02	CI
Abnova Corporation Announces Dividend Distribution for 2022, Payment on 5 July 2023	23-05-31	CI
Abnova Corporation Elects Members of the Company's Remuneration Committee	23-05-15	CI
Abnova Corporation Elects Members of the Company's Audit Committee	23-05-15	CI
Abnova Corporation Elects Board Members	23-05-15	CI
Abnova Corporation Approves Dividend Distribution for the Year 2022	23-05-15	CI
Abnova Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-10	CI
Abnova Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-01	CI
Abnova Corporation Announces Change of President	23-02-24	CI
Abnova Corporation Approves Dividend Distribution for the Year 2022	23-02-24	CI
Abnova Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-10	CI
Abnova Corporation(TWSE:4133) dropped from S&P Global BMI Index	22-09-19	CI
Abnova Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-09	CI
Abnova Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-04	CI
Abnova Corporation Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-21	CI
Abnova Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-10	CI
Abnova Taiwan Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-10	CI
Abnova Taiwan Corporation Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-03	CI
Abnova Taiwan Corporation Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-29	CI
Abnova Taiwan Corporation Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-10	CI
Abnova Corporation(TSEC:4133) added to S&P Global BMI Index	20-09-21	CI
Abnova Taiwan Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-11	CI

Chart Abnova (Taiwan) Corporation

Duration

Period

More charts

Company Profile

ABNOVA (TAIWAN) CORPORATION is a Taiwan-based company principally engaged in the manufacturing and sales of antibodies and proteins. The Company's products mainly include monoclonal antibodies, polyclonal antibodies, protein fragments, full-length proteins, active proteins, antibody pairs, fluorescence in situ hybridization probe and others. The Company's monoclonal and polyclonal antibodies are primarily applied in medical testing reagents, agricultural testing, industrial purification, medical treatment and other fields. Its proteins are mainly applied in medical testing reagents, agricultural testing, medical treatment, protein engineering and other fields. Its products are mainly traded in Taiwan, Americas and Europe.

Sector

Biotechnology & Medical Research

Calendar

2024-05-07 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Bio Therapeutic Drugs

	1st Jan change	Capi.
ABNOVA (TAIWAN) CORPORATION	-10.54%	58.89M
REGENERON PHARMACEUTICALS, INC.	+8.96%	105B
VERTEX PHARMACEUTICALS INCORPORATED	-1.43%	104B
ARGENX SE	+4.40%	22.94B
BIONTECH SE	-12.15%	22.34B
GENMAB A/S	-4.36%	19.25B
WUXI APPTEC CO., LTD.	-39.98%	17.08B
BEIGENE, LTD.	-10.04%	16.96B
NEUROCRINE BIOSCIENCES, INC.	+6.79%	14.16B
SAREPTA THERAPEUTICS, INC.	+38.61%	12.63B

Bio Therapeutic Drugs